TNF and alkaline phosphatase measurement: It is well documented that proinflammatory cytokines such as interleukin-1beta (IL-1β) and tumour necrosis factor-alpha (TNF-α), released at the early stage of AP, can further worsen gut dysmotility [18, 19], thus contributing to severe AP development [20].